Bacopasaponin C (Saponin)

Bacopasaponin C is a triterpenoid saponin isolated from Bacopa monnieri that exhibits antiparasitic properties and ATPase enzyme inhibition. This bioactive compound demonstrates potential therapeutic effects against Leishmania parasites through disruption of cellular energy metabolism.

Origin & History

Bacopasaponin C is a triterpenoid saponin (molecular formula C46H74O17) isolated from Bacopa monnieri, a wetland herb native to India and Australia. It is extracted from aerial parts or whole plant material using solvent-based methods followed by chromatographic purification such as HPLC.

Historical & Cultural Context

Bacopasaponin C itself has no documented traditional uses, being a modern isolate first reported around 2007. The source plant Bacopa monnieri has been used for approximately 3,000 years in Ayurvedic medicine for memory enhancement, anxiety reduction, and epilepsy, with benefits attributed to total bacosides rather than isolated compounds.

Health Benefits

• Antiparasitic activity: Demonstrated in vitro effects against Leishmania donovani (preclinical evidence only)
• ATPase inhibition: May disrupt cellular energy processes through enzyme inhibition (mechanism-based, preclinical)
• Potential cognitive support: As a component of Bacopa extracts studied for memory (indirect evidence only)
• Membrane modulation: Saponin structure suggests potential membrane-disrupting properties (theoretical)
• Research compound: Currently limited to laboratory studies with no human clinical evidence

How It Works

Bacopasaponin C inhibits ATPase enzymes, particularly those involved in cellular energy metabolism, disrupting ATP synthesis and utilization pathways. The compound demonstrates antiparasitic activity against Leishmania donovani through interference with parasite energy metabolism. As a component of Bacopa extracts, it may contribute to cognitive effects through modulation of neurotransmitter systems and cellular energy processes in neural tissue.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Bacopasaponin C were identified in the available research. Studies are limited to preclinical investigations showing antiparasitic activity against Leishmania donovani and ATPase inhibition in laboratory settings. While broader Bacopa monnieri extracts containing this compound have been studied for cognitive effects, no direct clinical outcomes can be attributed to Bacopasaponin C alone.

Clinical Summary

Research on bacopasaponin C remains limited to preclinical in vitro studies. Laboratory investigations have demonstrated antiparasitic activity against Leishmania donovani parasites, though specific concentration ranges and efficacy data require further documentation. ATPase inhibition has been observed in enzyme assays, but quantified inhibition percentages and therapeutic relevance remain unclear. Human clinical trials specifically examining bacopasaponin C as an isolated compound have not been conducted, limiting evidence for therapeutic applications.

Nutritional Profile

Bacopasaponin C is a purified triterpenoid saponin compound (not a whole food), so conventional macronutrient/micronutrient profiling does not apply. Key characterization data: Molecular formula C41H64O13, molecular weight approximately 752.9 g/mol. It is a dammarane-type triterpenoid glycoside with a jujubogenin aglycone core linked to a trisaccharide chain (arabinose, glucose, and rhamnose units). Typically isolated from Bacopa monnieri whole plant at concentrations of approximately 0.01–0.05% dry weight alongside other bacopasaponins (A, B, D, E, F). As a saponin, it is amphiphilic — possessing a lipophilic steroidal/triterpenoid backbone and hydrophilic sugar moieties — which governs its membrane-interacting behavior. Bioavailability is limited by poor aqueous solubility and susceptibility to hydrolysis in the gastrointestinal tract; gut microbiota may cleave glycoside bonds to release the aglycone (jujubogenin), which may be the primary absorbed form. No caloric, vitamin, mineral, or fiber contribution is attributed to this isolated compound. In standardized Bacopa monnieri extracts, total bacopasaponin content (including Bacopasaponin C) is often referenced at 10–20% of total bacosides by HPLC analysis.

Preparation & Dosage

No clinically studied dosage ranges for Bacopasaponin C in humans are available. In Bacopa monnieri extracts, it appears as a major saponin component, but standardization is typically based on total bacosides (20-50% w/w) rather than this isolated compound. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bacopaside III, other bacosides from Bacopa monnieri, phosphatidylserine, lion's mane extract

Safety & Interactions

Safety data for isolated bacopasaponin C in humans is not available due to lack of clinical studies. As a component of Bacopa monnieri extracts, it may share the generally recognized safety profile of the parent herb, though specific toxicity thresholds are unknown. Potential interactions with medications affecting cellular energy metabolism or antiparasitic drugs have not been studied. Pregnant and nursing women should avoid supplementation due to insufficient safety data for this isolated compound.